XTL Biopharmaceuticals (XTLB) Competitor Comparison
We are evaluating the key criteria listed to compare XTL Biopharmaceuticals (XTLB) against its competitors in the Biotechnology industry.
Market Capitalization
361 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
34 / 337Free Cashflow
0 / 352Quick Ratio
53 / 357Earnings per Share
45 / 359Dividend yield
0 / 6Total Cash
344 / 358Performance 3 years
150 / 368Performance 5 years
96 / 368Performance 10 years
210 / 368Linearity 3 years
85 / 368Linearity 5 years
51 / 368Linearity 10 years
234 / 368Total Rank
73 / 368Dividend Rank
48 / 368Valuation Rank
284 / 368Piotroski Rank
247 / 368Muliplier Rank
95 / 368Piotroski Rank - XTLB ranking 247 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.